Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0265-2023Class II

B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number...

Medical Action Industries, Inc. 306 / initiated 2022-09-15 / Terminated / root cause: labeling and UDI

Medical Action Industries, Inc. 306 began a recall of B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number corrected 11/23/2022) on . FDA classified it as Class II and gives the reason as "The kits were incorrectly labeled with an extended expiration date of 02/21/2024 instead of 02/10/2024". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0265-2023
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medical Action Industries, Inc. 306
Product
B. Braun CARESITE Port Access Kit w/Tegaderm, REF 375214, Central Venous (cardiac) Catheter Tray (REF number corrected 11/23/2022)
Product code
OFF Central Venous Catheter Tray
Reason for recall
The kits were incorrectly labeled with an extended expiration date of 02/21/2024 instead of 02/10/2024.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
Owens & Minor/Medical Action INDUSTRIES, INC. issued an URGENT: MEDICAL DEVICE FIELD CORRECTION to its sole consignee on 09/23/2022 by email. The notices explained the issue and requested they take the following actions: "Please review your inventory, and segregate and quarantine all affected Kits. If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. A labeling template is enclosed for printing labels which can be affixed on all affected kits in inventory. This label should be applied to each affected convenience kit and product case in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. If you prefer to have labels printed for your facility, please send quantity and end-user information to [email protected]. Any adverse events associated with the use of the affected products should be reported to [email protected]. The FDA requires that we account for all affected products. Therefore, please complete the attached Response Form and return to [email protected] as soon as possible even if you have no current product inventory. If you have any questions, please send an email to [email protected]."
Quantity in commerce
240 cases of 20 units
Distribution
US Nationwide distribution in the state of Pennsylvania.
Product codes and lots
UDI/DI 10809160283875, Batch/Lot number 298442

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0265-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0265-2023Class IITerminatedVoluntary: Firm initiated